Abstract
To compare vision function and self-reported quality of life (QoL) in patients with diabetic macular edema (DME) treated with intravitreous pegaptanib 0.3 mg or sham injection.
| Original language | English |
|---|---|
| Journal | Investigative ophthalmology & visual science |
| Volume | 52 |
| Issue number | 10 |
| Pages (from-to) | 7498-505 |
| Number of pages | 8 |
| ISSN | 0146-0404 |
| DOIs | |
| Publication status | Published - 2011 |
Keywords
- Adult
- Aged
- Aged, 80 and over
- Aptamers, Nucleotide
- Diabetic Retinopathy
- Double-Blind Method
- Female
- Humans
- Macular Edema
- Male
- Middle Aged
- Quality of Life
- Questionnaires
- Sickness Impact Profile
- Tomography, Optical Coherence
- Treatment Outcome
- Vision, Ocular
- Visual Acuity
- Young Adult
Fingerprint
Dive into the research topics of 'Changes in vision- and health-related quality of life in patients with diabetic macular edema treated with pegaptanib sodium or sham'. Together they form a unique fingerprint.Cite this
- APA
- Standard
- Harvard
- Vancouver
- Author
- BIBTEX
- RIS